Scandinavian Real Heart AB stock analysis
Want to see SE:HEART full AI Analyst Report?
Scandinavian Real Heart AB (HEART) Stock Price & Analysis
HEART Stock Chart & Stats
- Day’s Range
- SEK 14.70 - SEK 15.90
- 52-Week Range
- SEK 12.90 - SEK 23.70
- Previous Close
- SEK 15.60
- Volume
- N/A
- Average Volume (3M)
- 2,587
- Market Cap
- SEK 129.17M
- Enterprise Value
- SEK 151.30M
- Total Cash (Recent Filing)
- SEK 27.94M
- Total Debt (Recent Filing)
- SEK 5.40M
- Price to Earnings (P/E)
- ―
- Beta
- 0.15
- Next Earnings
- Feb 25, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Modest Leverage
The company’s modest debt burden provides greater financial flexibility than a highly leveraged medtech developer. Low leverage can reduce interest pressure and preserve options to fund research, regulatory work, and commercialization while the product remains pre-commercial.
Focused Artificial Heart Platform
A focused platform targeting severe heart failure addresses a significant clinical need and gives the company a clear long-term strategic identity. If development and validation succeed, the product could support a specialized position in advanced mechanical circulatory support.
Structured Development Path
The company is pursuing the key development stages required for a regulated implantable medical device, rather than relying only on an early concept. Progress across validation, regulatory preparation, and commercialization planning can build a foundation for future market access.
Bears Say
Pre-Revenue Business Model
The absence of a meaningful and repeatable revenue base means the company has not yet demonstrated commercial adoption or operating scale. Future funding and value creation therefore remain dependent on successfully converting development work into approved, sellable products.
Persistent Cash Burn
Sustained negative operating and free cash flow shows that the business cannot currently fund its activities internally. Continued research, validation, and regulatory work will likely require further financing, increasing execution dependence and pressure on future capital allocation.
Declining Equity Base
A shrinking equity base alongside continuing losses indicates that accumulated value is being consumed before commercial scale is reached. If this pattern persists, additional financing could become increasingly important and may create further dilution risk for existing shareholders.
HEART FAQ
What was Scandinavian Real Heart AB’s price range in the past 12 months?
What is Scandinavian Real Heart AB’s market cap?
When is Scandinavian Real Heart AB’s upcoming earnings report date?
How were Scandinavian Real Heart AB’s earnings last quarter?
Is Scandinavian Real Heart AB overvalued?
Does Scandinavian Real Heart AB pay dividends?
What is Scandinavian Real Heart AB’s EPS estimate?
How many shares outstanding does Scandinavian Real Heart AB have?
What happened to Scandinavian Real Heart AB’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Scandinavian Real Heart AB?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Scandinavian Real Heart AB
Scandinavian Real Heart AB (Publ), a Swedish enterprise established in 2007, specializes in the innovation and production of artificial heart devices. The company's core focus is the Realheart TAH, a total artificial heart engineered specifically to address severe cases of heart failure. Beyond this central project, their product portfolio also encompasses medical solutions such as the RealVAD, PulsePump, and Sternal Prosthesis. The firm operates from its base in Västerås, Sweden.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ina Laura Perkins
- Employees
- 18
- Website
- realheart.se
- Address
- Kopparbergsvägen 6, Västerås, VM, 722 13, SE
Scandinavian Real Heart AB (HEART) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 4 | 14 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 0 | 0 | 12 |
